| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | A01AB09 A07AC01 D01AC02 G01AF04 J02AB01 S02AA13 |
| UNII | 7NNO0D7S5M |
| EPA CompTox | DTXSID6023319 |
| InChI Key | BYBLEWFAAKGYCD-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H14Cl4N2O |
| Molecular Weight | 416.14 |
| AlogP | 6.45 |
| Hydrogen Bond Acceptor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 27.05 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 25.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Cytochrome P450 51 inhibitor | INHIBITOR | PubMed PubMed PubMed PubMed Wikipedia |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 17
Cytochrome P450 family 17A
Cytochrome P450 17A1
|
- | - | - | 243 | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 19
Cytochrome P450 family 19A
Cytochrome P450 19A1
|
400 | 600 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | - | - | - | 8.6 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 74.2-851.14 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 51
Cytochrome P450 family 51A
Cytochrome P450 51A1
|
- | 200 | 200 | - | - | |
|
Enzyme
Cytochrome P450
|
400 | 74.2-851.14 | 200 | 243 | 8.6 | |
|
Enzyme
Oxidoreductase
|
- | - | - | - | 77.2 | |
|
Enzyme
|
400 | 74.2-851.14 | 200 | 243 | 77.2 | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | - | - | - | 22 |
| Resources | Reference |
|---|---|
| CAS NUMBER | 22916-47-8 |
| ChEBI | 82892 |
| ChEMBL | CHEMBL91 |
| DrugBank | DB01110 |
| DrugCentral | 1800 |
| FDA SRS | 7NNO0D7S5M |
| Human Metabolome Database | HMDB0015242 |
| Guide to Pharmacology | 2449 |
| PharmGKB | PA450494 |
| PubChem | 4189 |
| SureChEMBL | SCHEMBL2866 |